U.S. Stock News

Evercore recently expanded its healthcare and biotechnology advisory platform, adding senior biotechnology-focused banker David Ke to its equity capital markets group in New York and featuring senior healthcare banker Bennett Blau at the 2026 Life Science Intelligence Summit. These moves highlight Evercore’s push to deepen sector expertise and client reach in biotechnology and life sciences at a time when healthcare capital formation remains a key focus for global investment banks. Now we’ll...

In recent days, IBM has unveiled an industry-first quantum-centric supercomputing reference architecture, expanded its AI collaboration with NVIDIA, and completed an approximately US$11.00 billion acquisition of data-streaming firm Confluent to strengthen its hybrid cloud and AI data platform. Together, these moves deepen IBM’s role at the intersection of quantum computing, high-performance AI infrastructure, and real-time enterprise data, potentially reshaping how large organizations build...

Vertiv Holdings Co (NYSE:VRT) has partnered with NVIDIA to deliver converged infrastructure for AI factory deployments. The collaboration introduces simulation ready digital power and cooling assets into NVIDIA's Vera Rubin DSX AI factory reference design and Omniverse DSX Blueprint. The goal is to speed up and de risk large scale AI projects through validated, repeatable, digitally coordinated infrastructure modules. For investors tracking AI infrastructure, this partnership provides...

Impinj recently entered privately negotiated agreements to repurchase approximately US$40.2 million of its 1.125% convertible notes due 2027 for cash, leaving about US$57.3 million outstanding after the March 16, 2026 closing. This sizable debt repurchase alters Impinj’s capital structure and could influence how investors assess its balance sheet strength and financial flexibility. Next, we’ll examine how Impinj’s sizable convertible note repurchase affects its existing investment narrative...

Earlier this month, Tenaya Therapeutics announced a research collaboration with Alnylam Pharmaceuticals to validate up to 15 gene targets for cardiovascular disease, receiving an upfront US$10 million payment, cost reimbursement over two years, and eligibility for as much as US$1.13 billion in development and commercial milestones. The collaboration highlights Alnylam’s effort to extend its RNAi platform into cardiovascular indications while outsourcing early target validation to a...

If you are wondering whether Rhythm Pharmaceuticals at around US$87.68 is still reasonably priced after its run, you are not alone. This article takes a closer look at what that level might mean for value focused investors. The stock has seen a 5.7% decline over the past week and a 10.6% decline over the last month, even after a 67.7% return over the past year and a very large gain over three years of about 4x. Recent coverage has highlighted investor interest following these sizeable multi...

T-Mobile US (NasdaqGS:TMUS) is collaborating with NVIDIA to pilot distributed edge AI infrastructure across its 5G network. The pilot aims to support real-time AI workloads for use cases such as smart cities, utilities, facility management, and industrial safety. This move extends T-Mobile's role from a traditional wireless carrier to a platform provider for enterprise-grade edge AI computing. T-Mobile US, trading at around $213.35, sits at the center of a broad shift where connectivity and...

Renasant (RNST) has drawn fresh attention after its recent share performance, with the stock down about 13% over the past month and 5% over the past 3 months, despite positive 1 year total returns. See our latest analysis for Renasant. The recent 13.4% 1 month share price decline, on top of a 5.4% 3 month share price fall, contrasts with Renasant's 4.6% 1 year total shareholder return. This suggests near term momentum is fading even as longer term investors remain modestly ahead. If you are...

AbbVie (NYSE:ABBV) is facing a revived whistleblower lawsuit alleging violations of the U.S. False Claims Act tied to federal drug pricing. The case brings renewed attention to AbbVie’s pricing practices within government programs and its potential legal exposure. Separately, AbbVie has entered a new multi year antibody discovery collaboration with Alloy Therapeutics. The Alloy agreement focuses on antibody discovery platforms intended to support AbbVie’s work on biologics and difficult drug...

Procter & Gamble (PG) is back in focus after rolling out premium upgrades across flagship brands, including Pampers AMORE diapers with five layer protection and higher absorbency, as well as deeper cleaning Swiffer PowerMop pads. See our latest analysis for Procter & Gamble. Despite the stream of premium launches across Pampers, Swiffer, Mr. Clean and BEVEL, the 30 day share price return of Procter & Gamble is a 5.37% decline, while its year to date share price return of 6.83% and 5 year...

Earlier this month, Abbott Laboratories reported that its FreeDM2 randomized controlled trial found the FreeStyle Libre continuous glucose monitoring system improved HbA1c, time-in-range, and quality-of-life outcomes for people with Type 2 diabetes on basal insulin, while also launching its latest XIENCE Skypoint coronary stent in India to support treatment of complex heart blockages. Together, these advances in diabetes care and cardiovascular devices highlight Abbott’s push to deepen its...

Earnings event puts Buckle in focus Buckle (BKE) is back on investors’ radar after reporting Q4 and full year 2026 results, with higher sales and net income across both periods compared with the previous year. The fresh numbers give you an updated snapshot of how this apparel retailer is converting its store base and online presence into revenue and earnings, which can be useful context if you already hold the stock or track the retail sector. See our latest analysis for Buckle. The recent Q4...

If you are wondering whether Talos Energy at around US$13.96 is still offering value or if you might be late to the story, this breakdown will help you put the current share price into context. The stock has seen a 7.9% return over the last 7 days, 6.4% over the last 30 days, 24.1% year to date, and 56.9% over the past year, which can influence how investors think about both upside and risk. Recent coverage around Talos Energy has focused on its position in the US energy sector and how the...

Wondering whether VinFast Auto's current share price reflects its true worth, or if the market is mispricing the story. The stock recently closed at US$2.95, with returns of 6.3% decline over 7 days, 10.3% decline over 30 days, 12.7% decline year to date, 9.5% decline over 1 year and 71.0% decline over 3 years, which can change how investors think about both risk and potential reward. Recent coverage has focused on VinFast Auto's position in the US listed auto space and its progress as an...

FedEx has surpassed United Parcel Service (NYSE:UPS) in market capitalization for the first time. The change in market value leadership comes as UPS pushes ahead with a broad business transformation. UPS is refocusing on higher margin areas such as healthcare, selling non core assets, and reducing its exposure to Amazon. For you as an investor, the shift in market capitalization between FedEx and UPS highlights how capital is being allocated across the global logistics sector. UPS remains...

Johnson Controls International (NYSE:JCI) has agreed to sell its residential HVAC business to Bosch, reallocating focus toward data center and service solutions. The company is expanding offerings for AI oriented data centers, including a partnership with NVIDIA to support advanced cooling needs. Management has highlighted backlog growth as evidence of strong demand for these focus areas. For investors tracking NYSE:JCI, this shift comes with the stock at $132.56 and a 1 year return of...

Why Bunge Global’s new buyback matters for shareholders Bunge Global (BG) has put a fresh buyback on the table, with Board approval to repurchase up to US$3b of stock. For you, that raises clear questions about capital allocation and valuation. See our latest analysis for Bunge Global. Since the buyback authorization on 10 March 2026, Bunge Global’s 1-day share price return of 1.89% and 7-day share price return of 5.19% sit within a stronger pattern, with a 90-day share price return of 35.57%...

Rising oil and diesel prices are increasing operating costs for gold miners, including Agnico Eagle Mines. NYSE:AEM has hedged a meaningful portion of its diesel exposure, helping protect its cost structure and profit margins. This hedging approach is setting Agnico Eagle apart from peers facing similar inflation pressures without the same level of protection. Agnico Eagle Mines, NYSE:AEM, is drawing attention as higher fuel costs ripple through the gold mining sector. With shares at...

Traeger, Inc. has already implemented a 1-for-50 reverse stock split on March 18, 2026, following stockholder approval earlier in the month to address a New York Stock Exchange notice that its shares had traded below US$1.00 for 30 consecutive trading days. This reverse split, combined with recent weak 2025 results and ongoing losses, highlights how Traeger is using financial tools rather than operational improvements alone to preserve its exchange listing. Next, we'll explore how Traeger's...

Shareholders are seeking to remove Starbucks (NasdaqGS:SBUX) board members Jørgen Vig Knudstorp and Beth Ford over concerns about labor negotiations and governance. The challenge follows a prolonged stalemate in union talks, with more than 680 Starbucks stores voting to unionize since 2021 without a final agreement in place. Proxy advisory firms have highlighted potential financial and reputational risks linked to ongoing labor disputes and perceived gaps in board oversight. For investors...

Earlier in March 2026, Dauch Corporation announced it would present at the Bank of America Global Automotive Summit on March 17, and SEC filings revealed Director David Walker bought 35,000 company shares, bringing his total holdings to 35,000 shares. This combination of a high-profile investor conference appearance and fresh insider buying drew attention to how leadership is positioned alongside shareholders. Next, we’ll examine how Director David Walker’s insider share purchase may...

In March 2026, Zenas BioPharma reported a wider quarterly and full-year net loss alongside higher revenue, while also securing up to US$250,000,000 in non-dilutive term loan financing and filing a US$78,589,885 shelf registration linked to an ESOP-related common stock offering. This combination of a larger loss, incremental revenue from partnerships, and substantial new funding reshapes how the company can support obexelimab’s commercialization plans and broader pipeline activities. With...

Cirrus Logic stock at a glance Cirrus Logic (CRUS) shares recently closed at US$135.87, giving the fabless semiconductor company a market value of about US$6.9b. Recent returns show mixed short term moves alongside stronger performance over the past year. See our latest analysis for Cirrus Logic. The recent 1-day share price return of 0.48% and 7-day share price return of 1.25% come after a softer 30-day share price return of a 6.05% decline. However, Cirrus Logic still shows stronger...

AAR announced that its Trax subsidiary previously agreed to provide Magnifica Air with cloud-hosted eMRO and eMobility solutions, enabling fully paperless maintenance and engineering operations from the airline’s launch. This deal underscores how AAR’s software can become embedded in airlines’ day-to-day maintenance workflows, potentially deepening customer relationships and recurring digital revenue streams. Next, we’ll examine how Trax’s role in enabling Magnifica Air’s paperless...